Vivos Inc (RDGL) stock
RDGLOTCSurgical & Medical Instruments & ApparatusFiscal year ends December 31
$0.05−0.00 (-2.51%)
Close on Oct 19, 2026Market cap $23.44MP/E –Yield –
Vivos shares outstanding
Diluted shares outstanding: the weighted share count used for earnings per share, adjusted for stock splits.
Vivos's shares outstanding was 491M at Jun 30, 2026. For fiscal 2025 it was 453M, up 10.5% from the year before. Over ten years it grew 69.5% a year on average. The highest annual figure on record is 453M in fiscal 2025.
Annual shares outstanding
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 453M | +10.5% |
| FY2024 | Dec 31, 2024 | 410M | +11.1% |
| FY2023 | Dec 31, 2023 | 369M | +4.9% |
| FY2022 | Dec 31, 2022 | 351M | +7.8% |
| FY2021 | Dec 31, 2021 | 326M | +46.3% |
| FY2020 | Dec 31, 2020 | 223M | +27.2% |
| FY2019 | Dec 31, 2019 | 175M | +215.7% |
| FY2018 | Dec 31, 2018 | 56M | +817.6% |
| FY2017 | Dec 31, 2017 | 6M | +125.1% |
| FY2016 | Dec 31, 2016 | 3M | +16.2% |
| FY2015 | Dec 31, 2015 | 2M | +479.6% |
| FY2014 | Dec 31, 2014 | 0M | +199.1% |
| FY2013 | Dec 31, 2013 | 0M | +72.0% |
| FY2012 | Dec 31, 2012 | 0M | +262.1% |
| FY2011 | Dec 31, 2011 | 0M | -69.5% |
| FY2010 | Dec 31, 2010 | 0M | – |
Quarterly shares outstanding
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | 491M | +8.2% |
| Q1 FY2026 | Mar 31, 2026 | 462M | +3.1% |
| Q4 FY2025 | Dec 31, 2025 | 455M | +6.5% |
| Q3 FY2025 | Sep 30, 2025 | 454M | +8.5% |
| Q2 FY2025 | Jun 30, 2025 | 454M | +12.4% |
| Q1 FY2025 | Mar 31, 2025 | 448M | +15.1% |
| Q4 FY2024 | Dec 31, 2024 | 427M | +14.2% |
| Q3 FY2024 | Sep 30, 2024 | 419M | +13.0% |
| Q2 FY2024 | Jun 30, 2024 | 403M | +9.6% |
| Q1 FY2024 | Mar 31, 2024 | 389M | +7.4% |
| Q4 FY2023 | Dec 31, 2023 | 374M | -0.1% |
| Q3 FY2023 | Sep 30, 2023 | 371M | +7.7% |
| Q2 FY2023 | Jun 30, 2023 | 368M | +7.1% |
| Q1 FY2023 | Mar 31, 2023 | 363M | +5.5% |
| Q4 FY2022 | Dec 31, 2022 | 374M | +10.5% |
| Q3 FY2022 | Sep 30, 2022 | 344M | +2.5% |
| Q2 FY2022 | Jun 30, 2022 | 344M | +4.8% |
| Q1 FY2022 | Mar 31, 2022 | 344M | +14.3% |
| Q4 FY2021 | Dec 31, 2021 | 339M | +35.0% |
| Q3 FY2021 | Sep 30, 2021 | 336M | +43.1% |
| Q2 FY2021 | Jun 30, 2021 | 328M | +89.5% |
| Q1 FY2021 | Mar 31, 2021 | 301M | +58.9% |
| Q4 FY2020 | Dec 31, 2020 | 251M | +36.8% |
| Q3 FY2020 | Sep 30, 2020 | 234M | +31.8% |
| Q2 FY2020 | Jun 30, 2020 | 173M | 0.0% |
| Q1 FY2020 | Mar 31, 2020 | 189M | +13.8% |
| Q4 FY2019 | Dec 31, 2019 | 183M | +279.9% |
| Q3 FY2019 | Sep 30, 2019 | 178M | +1511.0% |
| Q2 FY2019 | Jun 30, 2019 | 173M | +1983.1% |
| Q1 FY2019 | Mar 31, 2019 | 166M | +2264.5% |
| Q3 FY2018 | Sep 30, 2018 | 48M | +636.3% |
| Q2 FY2018 | Jun 30, 2018 | 11M | +90.1% |
| Q1 FY2018 | Mar 31, 2018 | 8M | +74.9% |
| Q4 FY2017 | Dec 31, 2017 | 7M | +116.0% |
| Q3 FY2017 | Sep 30, 2017 | 7M | +162.4% |
| Q2 FY2017 | Jun 30, 2017 | 6M | – |
| Q1 FY2017 | Mar 31, 2017 | 5M | – |
| Q4 FY2016 | Dec 31, 2016 | 3M | – |
| Q3 FY2016 | Sep 30, 2016 | 2M | – |
See a number that looks wrong?